Parmax Pharma Fund Raise of ₹19.28 Cr

Parmax Pharma Board Meeting Date

Parmax Pharma scheduled a board meeting for November 13, 2026 to approve unaudited quarterly and half-year results and shift its registered office. The filing is a prior intimation with no figures.

Parmax Pharma Management Change

Parmax Pharma's independent director Ami Shah resigned effective October 28, 2026. The exit follows a change in management and control of the company.

Parmax Pharma Other Announcement

Parmax Pharma Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.

Parmax Pharma Management Change

Parmax Pharma Ltd announced the resignation of Mr. Nikhil Uchat as an Independent Director of the Company, effective October 08, 2026.

Parmax Pharma Annual General Meeting

Parmax Pharma Ltd conducted its 32nd Annual General Meeting on September 29, 2026, covering routine business including financial statement adoption and board appointments.

Parmax Pharma Adverse Business Impact

Parmax Pharma reported a major fire incident at its Rajkot plant on September 28, 2026. Two employees were injured, and the company is currently assessing the financial damage.

Om Metallogic Fund Raise

Om Metallogic Ltd intimated a board meeting on 14 November 2026 to approve rights issue issue price, entitlement ratio, record date and issue dates. The rights issue follows BSE in-principle approval.

Virinchi Fund Raise of ₹30 Cr

Virinchi's board approved a Rs 30 Crore preferential issue of 2 crore convertible warrants at Rs 15 each. Subject to EGM approval, allottees include promoter Viswanath Kompella.

Value

₹30.00 Cr

Execution

Warrant tenure not exceeding 18 months from allotment

IIFL Finance Fund Raise of ₹6,414 Cr

IIFL Finance's board approved a preferential issue of convertible preference shares and warrants worth Rs.6,414.20 Crore. Shareholder approval is needed at a 4 December EGM.

Value

₹6,414 Cr

Bajaj Finance Fund Raise of ₹5,800 Cr

Bajaj Finance's special committee approved issuing 5.74 crore warrants to promoter Bajaj Finserv at ₹1,010 each. The issue raises about ₹5,800 crore.

Value

₹5,800 Cr

Cholamandalam Investment & Finance Company Fund Raise of ₹5,000 Cr

Cholamandalam Investment sent shareholders a postal ballot notice seeking approval for a Rs 5,000 crore QIP. E-voting runs November 10 to December 9, 2026.

Value

₹5,000 Cr

Execution

Allotment to be completed within 365 days of shareholder approval

HB Leasing & Finance Co Fund Raise

HB Leasing's board discussed fund-raising options on November 9, 2026, including equity and preference shares. No quantum or pricing is decided; advisers will be consulted.